NDC - HCPCS Crosswalk

Effective January 1, 2019 through March 31, 2019

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
52609-3001-0J9245ApoPharma USA, Inc.Inj melphalan hydrochl 50 mg50 MG1111
63323-760-20J9245FRESENIUS KABI USAInj melphalan hydrochl 50 mg50 MG1111
67457-195-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
67457-215-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
67457-579-01J9245Mylan InstitutionalInj melphalan hydrochl 50 mg50 MG1111
68152-109-00J9245Spectrum PharmaceuticalsInj melphalan hydrochl 50 mg50 MG1111
0143-9519-10J9250WEST-WARD PHARMACEUTICAL CORP.Methotrexate sodium inj5 MG21010100
0143-9830-01J9250West-Ward Pharmaceuticals CorpMethotrexate sodium inj5 MG11200200
0703-3671-03J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG21010100
0703-3671-93J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG21010100
0703-3675-01J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG1015050
0703-3675-91J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG1015050
0703-3678-01J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG401200200
0703-3678-81J9250Sicor Pharmaceuticals, Inc.Methotrexate sodium inj5 MG401200200
16729-277-03J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG1015050
16729-277-30J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG211010
16729-277-35J9250Accord Healthcare Inc.Methotrexate sodium inj5 MG401200200
61703-350-10J9250Pfizer Inc.Methotrexate sodium inj5 MG251050
61703-350-38J9250Pfizer Inc.Methotrexate sodium inj5 MG251050
61703-408-41J9250Pfizer Inc.Methotrexate sodium inj5 MG401200200
63323-122-50J9250Fresenius Kabi USA LLCMethotrexate sodium inj5 MG11200200
63323-123-10J9250Fresenius Kabi USA LLCMethotrexate sodium inj5 MG1015050
67457-466-10J9250Mylan InstitutionalMethotrexate sodium inj5 MG1015050
67457-480-40J9250Mylan InstitutionalMethotrexate sodium inj5 MG401200200
0143-9519-10J9260WEST-WARD PHARMACEUTICAL CORP.Methotrexate sodium inj50 MG210110
0143-9830-01J9260West-Ward Pharmaceuticals CorpMethotrexate sodium inj50 MG112020
0703-3671-03J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG210110
0703-3671-93J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG210110
0703-3675-01J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG10155
0703-3675-91J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG10155
0703-3678-01J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG4012020
0703-3678-81J9260Sicor Pharmaceuticals, Inc.Methotrexate sodium inj50 MG4012020
16729-277-03J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG10155
16729-277-30J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG2111
16729-277-35J9260Accord Healthcare Inc.Methotrexate sodium inj50 MG4012020
61703-350-10J9260Pfizer Inc.Methotrexate sodium inj50 MG2515
61703-350-38J9260Pfizer Inc.Methotrexate sodium inj50 MG2515
61703-408-41J9260Pfizer Inc.Methotrexate sodium inj50 MG4012020
63323-122-50J9260Fresenius Kabi USA LLCMethotrexate sodium inj50 MG112020
63323-123-10J9260Fresenius Kabi USA LLCMethotrexate sodium inj50 MG10155
67457-466-10J9260Mylan InstitutionalMethotrexate sodium inj50 MG10155
67457-480-40J9260Mylan InstitutionalMethotrexate sodium inj50 MG4012020
0078-0683-06J9261Novartis Pharmaceuticals CorporationNelarabine injection50 MG506530
0703-3985-01J9263Sicor Pharmaceuticals, Inc.Oxaliplatin0.5 MG101100100
0703-3986-01J9263Sicor Pharmaceuticals, Inc.Oxaliplatin0.5 MG201200200
0781-3315-70J9263Sandoz, Inc.Oxaliplatin0.5 MG1010100100
0781-3317-80J9263Sandoz, Inc.Oxaliplatin0.5 MG2010200200
0781-9315-70J9263Sandoz, Inc.Oxaliplatin0.5 MG101100100
0781-9317-80J9263Sandoz, Inc.Oxaliplatin0.5 MG201200200
0955-1725-10J9263Sanofi-AventisOxaliplatin0.5 MG11100100
0955-1727-20J9263Sanofi-AventisOxaliplatin0.5 MG11200200
0955-1731-10J9263Sanofi-AventisOxaliplatin0.5 MG101100100
0955-1733-20J9263Sanofi-AventisOxaliplatin0.5 MG201200200
16714-727-01J9263NorthStar Rx LLCOxaliplatin0.5 MG101100100
16714-728-01J9263NorthStar Rx LLCOxaliplatin0.5 MG201200200
16729-332-03J9263ACCORD HEALTHCAREOxaliplatin0.5 MG1010100100
16729-332-05J9263ACCORD HEALTHCAREOxaliplatin0.5 MG2010200200
25021-233-10J9263Sagent Pharmaceuticals IncOxaliplatin0.5 MG1010100100
25021-233-20J9263Sagent Pharmaceuticals IncOxaliplatin0.5 MG2010200200
43066-014-01J9263Baxter Healthcare CorporationOxaliplatin0.5 MG101100100
Page 61